Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 173

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study

Open access
Bello, Luca, Morgenroth, Lauren P., Gordish-Dressman, Heather, Hoffman, Eric P., McDonald, Craig M., Cirak, Sebahattin, CINRG investigators, Cnaan, A., Thangarajh, M., Abresch, R.T., Henricson, E., Viswanathan, V., McAdam, L., Mah, J., Tulinius, M., Ryan, M., Nevo, Y., Dubrovsky, A., Clemens, P., Connolly, A., Teasley, J., Bertorini, T., Webster, R., Kolski, H., Gorni, K., Lotze, T., Karachunski, P., Bodensteiner, J., Carlo, J. · 2016 · Neurology

Abstract

OBJECTIVE: To correlate time to loss of ambulation (LoA) and different truncating DMD gene mutations in a large, prospective natural history study of Duchenne muscular dystrophy (DMD), with particular attention to mutations amenable to emerging molecular treatments. METHODS: We analyzed data from the Cooperative International Neuromuscular Research Group Duchenne Natural History Study for participants with DMD single- or multi-exon deletions or duplications with defined exon boundaries (n = 186), or small mutations identified by sequencing (n = 26, including 16 nonsense point mutations). We performed a time-to-event analysis of LoA, a strong indicator of overall disease severity, adjusting for glucocorticoid treatment and genetic modifiers. RESULTS: Participants with deletions amenable to skipping of exon 44 had later LoA (median 14.8 years, hazard ratio 0.31, 95% confidence interval 0.14-0.69, p = 0.004). Age at LoA did not differ significantly in participants with deletions amenable to exon 45, 51, and 53 skipping, duplications, and small rearrangements. Nonsense mutation DMD also showed a typical median age at LoA (11.1 years), with a few outliers (ambulatory around or after 16 years of age) carrying stop codons within in-frame exons, more often situated in the rod domain. CONCLUSIONS: As exon 44 skipping-amenable DMD has a later LoA, mutation-specific randomization and selection of placebo groups are essential for the success of clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002891

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 173

Metadata

Authors
Bello, L., Morgenroth, L. P., Gordish-Dressman, H., Hoffman, E. P., McDonald, C. M., Cirak, S., CINRG investigators, Cnaan, A., Thangarajh, M., Abresch, R. T., Henricson, E., Viswanathan, V., McAdam, L., Mah, J., Tulinius, M., Ryan, M., Nevo, Y., Dubrovsky, A., Clemens, P., Connolly, A., Teasley, J., Bertorini, T., Webster, R., Kolski, H., Gorni, K., Lotze, T., Karachunski, P., Bodensteiner, J., & Carlo, J.
Venue
Neurology
Published
2016-07-26
Volume
87
Issue
4
Pages
401-409
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2470523364
Cited by
173
References
1
FWCI
4.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study. https://app.cochat.ai/papers/10.1212/wnl.0000000000002891
The paper
Bello, L., Morgenroth, L. P., Gordish-Dressman, H., Hoffman, E. P., McDonald, C. M., Cirak, S., CINRG investigators, Cnaan, A., Thangarajh, M., Abresch, R. T., Henricson, E., Viswanathan, V., McAdam, L., Mah, J., Tulinius, M., Ryan, M., Nevo, Y., Dubrovsky, A., Clemens, P., . . . Carlo, J. (2016). DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study. Neurology. https://doi.org/10.1212/wnl.0000000000002891

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.